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IntrOductIOn
Dermatitis is a skin disease and dermatitis diaper is the most 
frequent type of contact dermatitis in children. This disease involves 
an area of skin in infants which is usually covered by a napkin or 
diaper. Although the reason for this disease is not exactly known, 
the factors including mechanical friction, moisture, urinary and 
fecal contact, and pH changes contribute to its incidence [1]. The 
disease frequency has been reported 7 to 35% and even up to 50% 
in different studies.
The children have been reported to suffer from diaper dermatitis 
in the USA, Japan, Italy, and Iran 75%, 87%, 15% [2], and 34.9% 
respectively. This disease usually starts within the age of the third 
and 12th weeks and the peak of its incidence is the age of 6-12 
months [3]. 
This disorder could be a predisposing factor for bacterial and 
fungal infection because of causing wounds accompanied with 
scaling, itching, burning, dryness, scratching, skin rubbing, as well 
as stimulants and microbes penetration [4]. In addition, it causes 
restlessness, suboptimal breast feeding, and sleeplessness, which 
leads to repeated referring to paediatricians and increased concern 
and anxiety in parents [5]. Moreover, the repeated referring by 
parents imposes a large financial burden on them.
All these indicate that treatment of diaper dermatitis is very important. 
Currently, many treatments are available including topical use of 
Vaseline, zinc oxide [6], and vitamin A [7] and calendula [8].
In the case of fungal infections and symptoms exacerbations, topical 
anti-fungal drugs (such as clotrimazole, miconazole, and nystatin) 
[9] and corticosteroids [10] are used. Topical corticosteroids are 
common therapies of this disease, but long term consumption of 
them is associated with side effects such as epidermis atrophy, 
pituitary-adrenal axis suppression, Cushing’s syndrome, growth 
interruption [11], and Granuloma gluteal infants [12].
 
Calendula is an ointment that is a known drug in Iran and all over the 
world. This drug is used in atopic dermatitis, relief of itching, and no 
remarkable side effect is reported yet [8].
Proksch et al., in a study carried out by bathing with dead sea salts, 
concluded that the hydration of the skin and reduction of its redness 
is resulted from magnesium in the salt sea [13]. Besides, in another 
study, Dendra and his colleagues examined the use of magnesium 
salt in the skin wound and concluded that the impact of the product 
depends on the method and type of its use [14].
Regarding these complications and since magnesium (Mg) has been 
referred as anti-inflammatory, wound-restorative, and inflammation-
declining in atopic dermatitis, therefore, we aimed to determine the 
efficacy of topical application of the cream containing Mg 2% on 
treatment of diaper dermatitis in children referring Paediatric Ward 
of Hajar Hospital, Shahrekord Iran.
MAterIAls And MethOds
In this double-blinded clinical trial study, the study population 
comprised 64 children [Table/Fig-1] less than two years old with 
diaper dermatitis admitting in Paediatric Ward of Hajar Hospital, 
Shahrekord. The inclusion criteria were patients aged less than two 
years with diaper dermatitis diagnosis and the exclusion criteria 
were co-morbidities like candida infection in groin, psoriasis, zinc 
deficiency, and use of other drugs for diaper dermatitis. Random 
Sampling was done lasting for six months. Groups were assigned 
through selecting one from every pair. The patients were examined 
once a day for the first five consecutive days of the study.
The sampling was done randomly and 32 children were included in 
each group. As far as we searched, no reliable criterion was found 
to determine lesion severity and therefore duration of recovery was 
used. 
The patients underwent treatment with combined calendula and Mg 
2% cream in case group and with calendula cream in control group. 
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ABstrAct
Introduction:  Diaper dermatitis is referred to the inflammation 
in outer layers of the skin in the perineal area, lower abdomen, 
and inner thighs. The lesions are maculopapular and usually 
itchy, which could cause bacterial or candida infection, and 
predispose the infants to penis or vaginal and urinary infection 
and lead to discomfort, irritability, and restlessness. The drugs 
which have been so far administered for this disease (topical 
steroids) cause special complications for the sensitive skin in 
this area. Magnesium (Mg) is known for its anti-inflammatory 
and wound-healing properties. 
Aim: The aim of the present study was to study the effect of the 
cream containing Mg 2% on treatment of diaper dermatitis and 
diaper rash in children.
Materials and Methods: In this clinical trial study, 64 children 
aged less than two years old with diaper dermatitis referring 
Paediatric Ward of Hajar Hospital were randomly assigned to 
two groups of 32. Group one was treated with the combined 
cream Mg 2% and Calendula and group two with Calendula 
cream alone. The duration of recovery was compared between 
the two groups.
results: The duration of recovery was significantly lower in 
the intervention group than the control group (p-value<0.001), 
but there was no significant difference in the lesions size and 
diapers’ number between the two groups.
conclusion: Based on the finding of this study, Mg is effective 
on treatment of diaper dermatitis and could be used for treating 
diaper dermatitis and other types of dermatitis. 
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Perineal Genital Groin total
Lesion
site
Case group 65.6% 15.6% 18.8% 100%
Control group 56.2% 3.1% 40.6% 100%
Aggregate 60.9% 9.4% 29.7% 100%
X2 = 5.47    p = 0.065
Mean Standard 
deviation
p-value t value Confidence interval
lower 
limit
upper 
limit
Age
 (year
Case 
group
1.9375 0.84003 0.625 0.491 -0.28755 0.47505
Control 
group
1.8438 0.67725
Recovery 
duration 
(day)
Control 
group
3.25 0.67 0.00 1.102 0.788 2.726
Case 
group
1.50 0.50
[table/Fig-2]: Lesion site.
[table/Fig-3]: Age and recovery duration in case and control groups.
The drugs used in this study included magnesium USP (Merck, 
Germany) and Calendula ointment (Dineh, Iran). The cream was 
used three times a day on the rash area while diaper changing. 
The follow-up was done twice a day until complete recovery. 
Furthermore, the drug administration continued until complete 
recovery, that is, removal of inflammation, redness, and lesions. 
Finally, the patient’s recovery was determined based on the 
duration. The data were analysed by SPSS 16 using t-test and 
chi-square. 
This research project was approved at Ethics Committee of 
Shahrekord University of Medical Sciences (ethical code: 8-4-91) 
and registered as IRCT2012110510222N2 in Iranian Registry of 
Clinical Trials (IRCT). Informed consent was obtained from all infants’ 
parents.
results
In this study, 64 children aged less than two years were entered. 
Mean age was 1.9 ±0.8 years in the case group and 1.9±0.6 
years in the control group there is no significant difference between 
means (p-value=0.6). The two groups were matched by lesion 
site and there was no significant difference in this regard) (0.065) 
[Table/Fig-2]. In the case group, 18.8% of the patients had history 
of dermatitis and in the control group, 4.9% of infants that there 
was no significant difference between the two groups (p-value =0.2) 
in this respect. Mean duration of recovery was 1.5±0.5 days in the 
case group and 3.25 ± 0.67 days in the control group. The mean 
duration of recovery was significantly lower in the case group than 
the control group [Table/Fig-3].
dIscussIOn
The present study aimed to determine the efficacy of topical 
application of the cream containing Mg 2% on treatment of diaper 
dermatitis. In this study, 64 children less than two years were 
studied. According to the findings of this study, the mean duration 
of recovery was 1.5 ± 0.5 days in the case group and 3.25 ± 0.67 
days in the control group. The mean duration of recovery was 
significantly lower in the case group than the control group (p-value 
<0.001).
[table/Fig-1]: CONSORT 2010 Flow Diagram
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In James et al., study, the effect of Mg-aluminum hydroxide stearate 
on eczema dermatitis was investigated and the contribution of 
topical cream to protection from the skin against allergens and 
external stimulants was indicated. The notable point was that skin 
restoration was mainly through moisture and skin lipid replacement 
and hence the symptoms of dermatitis decreased. 
This cream relieves irritation and itching in different types of dermatitis 
including atopic, contact allergic as well as contact dermatitis and 
has been recommended to be applied twice to three times a day 
[15].
In a study conducted in China, the effect of Mg was studied on 
contact allergic dermatitis in mice. In that study, the drug was 
parenteral. Pathologic changes in the mice ears were studied using 
staining under optical microscope. The results indicated that the ear 
inflammation and erythema decreased significantly and that specific 
concentrations of Mg had therapeutic properties for allergic contact 
dermatitis in the mice [16].
In a study by Pastorfid et al., topical application of zinc chloride 
spray and Mg hydroxide ointment were studied in patients with 
abdominal and perineal incisional wounds and it was pronounced 
decrease in the wound size and recovery duration, better control 
of infection, and control of clear pain was noted in the patients in 
comparison to those receiving placebo. In addition, no side effect 
was observed in the patients [17].
In a study by Shaikh ZI et al., upon treating recurrent melasma 
using topical 5% Mg ascorbyl phosphate and fluorescent pulsed 
lighting Asian patients, 65 patients with this disease underwent 
treatment with 5% Mg ascorbyl phosphate and fluorescent pulsed 
light for approximately 12 weeks, which contributed to decrease in 
hypermelanosis in these patients [18].
In a study by Iraji and Rezazadeh to compare the efficacy of topical 
application of sucralfate and hydrocortisone on diaper dermatitis, 64 
one- to 24-month infants with diaper dermatitis were enrolled into 
the study. A total of 32 patients underwent treatment with sucralfate 
4% and 32 patients with hydrocortisone cream. The patients were 
followed up until complete recovery. The results indicated that topical 
sucralfate had a similar effect to that of topical hydrocortisone on 
diaper dermatitis treatment [19]. 
cOnclusIOn
It was concluded that topical application of this cream could 
contribute importantly to pain relief and mothers’ and infants’ 
comfort because of speedy recovery of the lesion and diaper rash-
caused inflammation. Furthermore, mothers should be advised to 
wash the infants appropriately and change the diaper repeatedly. 
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